Viking Therapeutics, Inc.

Home » Viking Therapeutics, Inc.

Secondary

Viking Therapeutics, Inc.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders.

Symbol

VKTX

Last Closing Price
$2.74

Shares
4,700,000

Effective Date
December 7, 2017

Underwriters
William Blair

To view the prospectus for Viking Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253